Global Vulvodynia Treatment Market To Grow At A CAGR Rate Of 7% During 2022-2028

05-Jul-2022 | Zion Market Research

The global vulvodynia treatment market was worth around $5.4 billion in 2021 and is predicted to grow to around $8 billion by 2028 at a CAGR rate of 7% over the forecast period.

The vulvar pain and the discomfort developing around that area are called vulvodynia. The reproductive stages are affected badly because of this disease. The pain caused due to this disease can cripple even small movements of the body making a life-disrupting scenario.

There are some biological, physiological, and interpersonal factors that affect the illness to a large extent and aggravate the pain to unbearable levels. The vulvar actually expands and contracts alternatively and the movement is called vulvodynia. It disrupts the sex life of a woman by inducing a lot of pain in her reproductive organs. It also makes the body parts static and renders less mobility for women.

They are classified into localized vulvodynia and generalized vulvodynia. Localized vulvodynia affects only the specific parts and is easily curable. Generalized vulvodynia affects the internal parts and deteriorates the agility of a woman. The basic cause of the disease could be anything but sometimes improper insertion of tampons to some irregular sex. Wearing tight underpants could also trigger the disease. It is common to all women of all ages and is quite sensitive for a healthy life.

Covid-19 has a delirious impact on the global vulvodynia treatment market. All medical procedures and treatment took a hit because people were restricted from going to hospitals or clinics. They were cooped up at home and take self-treatments for any kind of minor illnesses. The demand for vulvodynia treatment went down massively due to people’s hesitation on taking any cure because of curfews and lockdowns. There was also a shortage of raw materials, equipment, and drugs for the treatment because of commutation issues during the pandemic. All of this led to deprecation in the market rate.

Global Vulvodynia Treatment Market

The growing focus on women’s healthcare issues along with the blooming awareness of illness spikes up the market growth. The knowledge about the illness also has been spiking up to a great extent which provokes people to take the treatment subsequently. The generic medications for the treatment of vulvodynia disease are also available and accessible which makes the demand for treatment go up.

There is ample technological advancement in the area of vulvodynia treatment and many companies have started focusing on the infrastructures & equipment needed to cure the disease. Gynecologists have gained knowledge about this disorder and have come up with the leverage of anesthetics, gels, and ointments for curing it. These factors have triggered a huge growth in the global vulvodynia treatment market thereby increasing its consumption as well.

Medications for female sexual dysfunction seem to have gained some prominence due to the rising cases. Pain killers have been prescribed to a large extent which makes the treatment more accessible and common. This triggers a market expansion and a huge demand thereby increasing the market rate considerably.

Although, the side effects of the medication associated with treatment and lack of awareness of such a disease cripples the market growth extensively. There is also a considerable shortage of effective treatment methods which further hamper the market growth.

The global vulvodynia treatment market is fragmented into types, indications, end-users, and regions. The type is classified into biofeedback therapy, intralesional injections, and oral treatment. The indication is divided into generalized vulvodynia and localized vulvodynia. The end users are hospital pharmacies, retail pharmacies, and online pharmacies.

North America comes across as the major contributor to the global vulvodynia treatment market. This is because of the growing cases and rising infertility issues amongst women. There is also an increased focus and emergence of many research programs and analyses on the treatment of the disease which amplifies the market rate in the region. Western Europe also has a major contribution to the market growth due to the popularity of these treatment methods in all clinics and hospitals. The generic medicines involved in the treatment is abundant in the Asia-Pacific region which boosts the market growth exclusively.

Major players in the global vulvodynia treatment market are Allergan plc, Johnson & Johnson Services Inc, Pfizer Inc, GlaxoSmithKline plc, AstraZeneca plc., Eli Lilly, Sanofi, Hisamitsu Pharmaceutical Co. Inc, and National Vulvodynia Association.

Recent Development:

  • In June 2020, Allergen introduced vibrators to treat vulvodynia pelvic pains and also for more health benefits.
  • In Nov 2020, NIH-funded researchers develop a non-surgical treatment method for endometriosis and vulvodynia.

Browse the full Vulvodynia Treatment Market By Type (Biofeedback Therapy, Intralesional Injections, and Oral Treatment), By Indication (Generalized Vulvodynia and Localized Vulvodynia), By End-Users (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028. Report at https://www.zionmarketresearch.com/report/vulvodynia-treatment-market

The global vulvodynia treatment market is segmented as follows:

By Type

  • Biofeedback Therapy
  • Intralesional Injections
  • Oral Treatment

By Indication

  • Generalized Vulvodynia
  • Localized Vulvodynia

By End-Users

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed